Bevacizumab Plus Atezolizumab Following Progression on Atezolizumab Monotherapy in Pretreated Patients With NSCLC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Thoracic Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Bevacizumab plus atezolizumab following progression on atezolizumab monotherapy in pretreated non-small cell lung cancer patients: An open-label, two-stage, phase II trial
J Thorac Oncol 2022 Apr 12;[EPub Ahead of Print], J Lee, J Koh, HK Kim, S Hong, K Kim, S Park, HA Jung, JM Sun, SH Lee, JS Ahn, K Park, MJ AhnFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.